Dr. Cornelia Baldermann

Federal Office for Radiation Protection, Germany

Dr. Cornelia Baldermann holds a PhD in Biology and has been working as a scientific expert at the Federal Office for Radiation Protection (BfS) since 2002. Her tasks within UV-radiation are 1) to evaluate health effects, and to develop and implement suitable radiation protection concepts, 2) to initiate and coordinate research projects funded by the Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (BMU), 3) to advise the Federal Government and support the BMU in drafting and implementing statutory regulations, 4) to coordinate the UV Protection Alliance, which currently focuses on the establishment of structural prevention measures for the prophylaxis of UV-related diseases, in particular skin cancer, 5) to hold lectures and training courses for multipliers on this topic and 6) to work closely with the WHO as part of the INTERSUN programme (e.g. development of the WHO brochure "Artificial tanning devices: public health interventions to manage sunbeds").

Prof Dr Petra Boukamp

German Cancer Research Center, Heidelberg, and Institute for Environmental Medicine, Düsseldorf, Germany

Petra Boukamp is the former head of the Division “Genetics of Skin Carcinogenesis” at the German Cancer Research Center (DKFZ) in Heidelberg and still leads a team working on UV skin carcinogenesis at the Leibniz Institute for Environmental Medicine (IUF) in Düsseldorf, Germany.

The focus of her research has been on the role of skin in aging and cancer by concentrating on epidermal stem cells, skin cancer genetics and their functional consequences, as well as developing cellular tools (HaCaT in vitro carcinogenesis model) and 3D organotypic skin models (long-term skin and skin cancer equivalents) as a paradigm for human UV-dependent skin cancer. In addition, her work on the role of telomeres and telomerase in the scenario of aging and cancer is well appreciated. Besides, Petra is coordinating the Bmbf funded consortium (KAUVIR) on UV radiation in aging and cancer.

Petra serves as a member of the German Cancer Aid (DKH), as a contact person for several European grant agencies and as an Associate Editor for the International Journal of Cancer. Besides a number of awards, in 2017 Petra received the prestigious “German Cancer Award” of the German Cancer Society.

Prof Dr Scott Byrne

University of Sydney, Australia

PhD, FFSc (RCPA) by Research | Associate Professor

Scott Byrne is an Associate Professor based at The Westmead Institute for Medical Research. He is well known for his discoveries related to UV-immunosuppression, in particular that both UVB and UVA modulate the immune response and that UV suppresses immunity via activation of regulatory B cells.

A focus of Scott’s research has been to design novel methods of blocking the damaging effects of UV by targeting immune cells and molecules. His team discovered that the CXCR4 antagonist AMD3100 blocked UV-immunosuppression and carcinogenesis. More recently, he revealed that depleting UV-activated regulatory B cells inhibits skin tumour growth and metastasis.

In recognition of his contributions, Scott has been the recipient of a number of prestigious awards including The European Society for Photobiology Young Investigator Award (2011), The Asia and Oceania Society for Photobiology Award for Young Scientists (2015), and The Finsen Lecturer Award from the International Union of Photobiology (2019).

Peter Dalum

Danish Cancer League

Executive Project Manager. M.A. Ph.D.

Peter have worked in the prevention field since 1998 and have worked as a developer of a wide range of different approaches: E.g. educational materials, personalized Internet smoking cessation programs, counsellor programs, public affairs strategies, media- and social media campaigns, with in the areas of ‘tobacco’, ‘alcohol’ and ‘Uv-exposure’. As a researcher Peter have a strong experience with systematic and evidence based intervention development and the planning method ‘Intervention Mapping’ and have published in both the quantitative and qualitative field. Since 2012, head of the multicomponent Danish Sun Safety Campaign.

Prof Dr Harry de Koning

Dept of Public Health, Erasmus MC University Medical Center Rotterdam, the Netherlands

MD PhD

I am Deputy Head and Professor of Public Health & Screening Evaluation, Department of Public Health, Erasmus MC University Medical Centre, Rotterdam, The Netherlands. My major scientific contributions are in the areas of (1) designing, running and evaluating (often large-scale) multidisciplinary population-based randomized controlled screening trials to establish the efficacy of screening, (2) evaluating active (inter-)national screening programs and clinical tests to establish effectiveness and (3) guiding public health policies on screening and primary prevention using predictions of favourable and unfavourable effects and the cost of interventions, based on micro-simulation modelling of the natural history of disease, risk-prediction modelling and cost-effectiveness and cost-utility analyses. Our multidisciplinary and international research results in recommendations on whether or not to introduce screening, surveillance or other preventive interventions for specific diseases and on policy decisions to introduce it in specific ways, either at population level or in (high risk) patients.

I am PI of the ROBINSCA trial through an Advanced Researcher Grant (2011), to assess the (cost-) effectiveness of screening for cardiovascular disease. I am PI of the NELSN lung cancer screening trial.

Prof Jeff French

PhD, MBA, MSc, DipHE, BA, Cert.Ed.

Professor Jeff French is a global thought leader in the fields of behavioural influence, Social Marketing, social communication and citizen focused programme planning and evaluation. Jeff has published over 100 academic papers and five books plus numerous guides and tool kits on these subjects. Jeff is a visiting Professor at Brighton University and a Fellow at Kings College London University and teaches at four other universities on a regular basis. Previously Director of Policy and Communication at the UK Health Development Agency and a senior civil servant in the UK Department of Health. In 2004 Jeff led the UK government review of Social Marketing and set up the National Social Marketing Centre in 2005. In 2009 Jeff became the CEO of Strategic Social Marketing Ltd. Strategic Social Marketing works with Governments, some of the world’s biggest private companies, NGO’s, as well as global organisations such as WHO, UNISEF on the development and evaluation of programmes that aim to influence positive social and health behaviour. Jeff is a member of several national and international policy committees and a member of the Editorial Boards of five professional Journals.

Louisa Gordon

Team Head - Health Economics, QIMR Berghofer Medical Research Institute, Australia

PhD, MPH

Prof Louisa Gordon is Team Head of Health Economics at QIMR Berghofer Medical Research Institute. Louisa is a health economist and holds a PhD in Public Health, Masters of Public Health and Bachelor of Economics. Louisa has over 15 years’ health economics experience performing economic evaluations, decision-analytic modelling and applied economic research. Her key research interests are in the areas of skin cancer prevention, supportive care interventions for cancer survivors, costing studies and the financial burden of cancer to families. Prior to 2016, she undertook health technology assessments commissioned by the Australian Commonwealth Department of Health for Medicare funding decisions.

Dr. Rüdiger Greinert

Euroskin

Secretary General

TBC

Gery P. Guy Jr.

Team Lead, Division of Overdose Prevention, Centers of Disease Control and Prevention (CDC), USA

PhD, MPH

Gery Guy, PhD, MPH is a Lead Health Scientist in the Division of Overdose Prevention at the U.S. Centers for Disease Control and Prevention (CDC). Dr Guy has also served as a Health Economist in Division of Cancer Prevention and Control at CDC. In this role he examined the economic burden of cancer and cancer survivorship, the economics of skin cancer prevention, and the impact of skin cancer prevention polices. Dr. Guy’s current work examines opioid prescribing, opioid use among cancer survivors, and the impact of policies and interventions on opioid prescribing and drug overdoses.

Dr. Guy received his MPH in Health Policy and his PhD in Health Services Research and Health Policy from Emory University. He completed a post-doctoral fellowship in Prevention Effectiveness at the CDC. He has authored over 100 peer-reviewed publications, government reports, and book chapters, and served as a lead writer of the U.S. Surgeon General’s Call to Action to Prevent Skin Cancer. He has received a number of awards for his work in public health including the 2014 Presidential Early Career Award for Scientists and Engineers.

Dr. Carolyn Heckman

Rutgers Cancer Institute of New Jersey, USA

Associate Professor of Medicine

Dr. Carolyn Heckman is an Associate Professor at Rutgers Cancer Institute of New Jersey, USA. She earned her PhD in Counseling Psychology and is a licensed psychologist. Her research interests include skin cancer prevention and detection, digital interventions, and dissemination and implementation science. She developed and is currently disseminating the efficacious UV4.me skin cancer risk reduction intervention for young adults and has run the US National Council on Skin Cancer Prevention’s “Don’t Fry Day” social media campaign for the past four years. Her research has been funded by the US National Cancer Institute, American Cancer Society, and Pfizer, and she has published over 100 peer-reviewed papers.

Dr. Monika Janda

The University of Queensland

Professor for Behavioural Science

Prof Monika Janda is a Professor in Behavioural Science at the Centre for Health Services Research, The University of Queensland, Faculty of Medicine. She is a health psychologist with a research background in cancer prevention and quality of life research. She has developed the Healthy Text and SunText interventions, which aim to foster people achieving their sun safety aims, by providing knowledge, motivation and social support. Her research has been funded by the Australian National Health and Medical Research Council, Cancer Australia, The Australian Cancer research Foundation and the Harry Lloyd Foundation.

Robyn Lucas

Research School of Population Health, College of Health and Medicine The Australian National University

Professor, Environment, Climate and Health & Head, National Centre for Epidemiology and Population Health

Prof Robyn Lucas is an epidemiologist and specialist public health physician. She is Head of the National Centre for Epidemiology and Population Health at the Australian National University in Canberra, Australia. She has recently retired as the lead author for health for the United Nations Environment Programme Environmental Effects Assessment Panel for the Montreal Protocol on Ozone Depletion. Her research focuses on understanding the balance of risks and benefits of sun exposure, and tailoring public health messages for optimal sun exposure. She has had a particular interest in vitamin D, and non-vitamin D benefits of sun exposure for autoimmune disorders such as multiple sclerosis. She works in multi-disciplinary teams with collaborations nationally within Australia and internationally to understand the effects of sun exposure on immune function, public health messaging framed around the UV index and the moderating effects of skin colour, and the public health, research, and clinical implications of inaccurate and imprecise vitamin D assays. As an Australian and New Zealander, she comes from a context of very high skin cancer incidence, so that considerations of public health messages around sun exposure are nested within that context.

Craig Sinclair

Cancer Council Victoria, Australia

Head of Prevention at the Cancer Council Victoria

Adjunct Associate Professor Craig Sinclair is the Head of Prevention at the Cancer Council Victoria, Australia where he is responsible for the development and delivery of population-wide cancer prevention and screening programs. He is also Director of the World Health Organisation's (WHO) Collaborative Centre for UV Radiation and co-chair of the World Meteorological Organisation’s (WMO) UV and Ozone Scientific Advisory Group. He has expertise in skin cancer, vitamin D and sun protection and population health approaches to reduce cancer risk. He is an author of over 35 peer reviewed publications including the most recent WHO publication on artificial tanning devices: Public Health Interventions to Manage Sunbeds. In 2010, the United States Environment Protection Agency (EPA) awarded Craig with an EPA Montreal Protocol Award for his substantial contribution to human health protection.

Dr Mariano Suppa

Hopital Erasme Brussels, Belgium

Mariano Suppa is an Associate Professor of Dermatology at the Université Libre de Bruxelles (Belgium). Mariano graduated summa cum laude in Medicine & Surgery and then in Dermatology at the University of L’Aquila (Italy). He subsequently got his PhD at the Université Libre de Bruxelles with a thesis on prevalence, determinants and risks associated with sunbed use in Europe. His education also included fellowships at the Departments of Dermato-Oncology of the Université Paris-Sud/Institut Gustave Roussy (France) and of the University of Leeds (UK). Previous work experiences included a clinical research fellowship for the European Organization for Research and Treatment of Cancer (EORTC) Melanoma Group. His main clinical/research interests are dermato-oncology, non-invasive skin imaging, skin cancer prevention, hidradenitis suppurativa, epidemiology and biostatistics. He is author of 40 original articles on peer-reviewed journals and 5 book chapters. A frequent speaker in national/international meetings, he is member of several dermatological societies.

Emilie van Deventer

World Health Organisation

Team Leader Radiation Program, Department of Public Health, Environmental and Social Determinants of Health | World Health Organisation

TBC

Prof Dr Marit. B. Veierød

Department of Biostatistics, University of Oslo, Norway

Marit B. Veierød is Professor and Group Leader at the Oslo Centre for Biostatistics and Epidemiology, and Deputy Chair at the Department of Biostatistics, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo. She holds a PhD in biostatistics and epidemiology. For more than 20 years, she has been working with population based prospective studies of lifestyle factors and chronic diseases, and with a particular interest in skin cancer. Norway is now ranked third in the world in melanoma incidence, and melanoma and squamous cell carcinoma are among the cancers increasing most in Norway. Prof. Veierød and her group are studying the complex associations between pigmentation factors, UV exposure from the sun and indoor tanning and risk of melanoma and squamous cell carcinoma. An important aim is to contribute to skin cancer prevention, and in the future, more personalized prevention strategies. Prof. Veierød is a member of the Norwegian Academy of Science and Letters and she has published over 175 peer-reviewed journal papers and 3 textbooks.

Prof David Whiteman

AM, FAFPHM, FAHMS, FSCCA (Hon)

Acting Director : QIMR Berghofer Medical Research Institute
Head, Cancer Control Laboratory : QIMR Berghofer Medical Research Institute
Coordinator, Melanoma and Skin Cancer Research Centre, Brisbane, Queensland, Australia

Professor David Whiteman is a medical epidemiologist with a special interest in the causes, prevention and control of cancer. He received his medical degree from the University of Queensland in 1991, and his PhD in cancer epidemiology in 1997. He is Principal Investigator of QSkin, a large prospective cohort study which has gathered clinical, phenotypic and genetic data on more than 45,000 people to unravel the causes of skin cancer. In addition to his research activities, he is Acting Director of QIMR Berghofer, a Fellow of the Australian Academy of Health and Medical Sciences, a Fellow of the Australasian Faculty of Public Health Medicine, and Honorary Fellow of the Skin Cancer College of Australasia. In 2019, he was made a Member of the Order of Australia for his services to cancer epidemiology.

Dr. Roberto Zanetti

IACR, International Association of Cancer Registreis Turin, Italy

Graduated in medicine at Torino University, Italy. PhD in biostatistics.

Junior Epidemiologist and then Director at the Piedmont Cancer Registry (1978-2018).

Coordinator of networks for measuring the impact of cancer (incidence, survival, prevalence and mortality) at national and international level. Editor of the Italian quinquennial Report Cancer in Italy, and of the Volume XI of the WHO-IARC compendium Cancer Incidence in Five Continents. Editor of the Italian version of the UICC-TNM staging manual.

Other main research interests: analytical studies on the etiology of Melanoma, Breast cancer, Lymphomas, Kaposi sarcoma, Pleural mesothelioma; on the evaluation of Breast, Cervix and Colon screening programs; on the analysis of costs and performance in cancer registration.

Active in global cooperation in cancer control: member of the Board of Director of the UICC (Union for International Cancer Control) and Past-President of the IACR (International Association of Cancer Registries)